Hye Suk Hwang

Hye Suk Hwang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
Vinh Van TranVinh Van Tran
Vinh Van Tran
NTNhu Hoa Thi Tran
Nhu Hoa Thi Tran
HHHye Suk Hwang
Hye Suk Hwang
Mincheol ChangMincheol Chang
Mincheol Chang

8 March 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
HHHye Suk Hwang
Hye Suk Hwang
YLYoung-Tae Lee
Young-Tae Lee
KKKi-Hye Kim
Ki-Hye Kim
HSHo Seo
Ho Seo
KYKap Seung Yang
Kap Seung Yang
SKSang-Moo Kang
Sang-Moo Kang
The roles of the Fc receptor (FcR) in protection or inflammatory disease after respiratory syncytial virus (RSV) vaccination and infection remain unknown. Virus-like particles containing RSV fusion proteins (RSV F-VLPs) induce T-helper type 1 antibody responses and protection against RSV. Heterologous RSV F-VLP prime and formalin-inactivated RSV (FI-RSV) boost vaccination has been reported to be effective in providing protection without inflammatory disease. Here, we investigated whether the FcRγ-chain is important for immune protection by the heterologous F-VLP and FI-RSV vaccination using FcRγ-chain knockout (−/−) mice. RSV F-VLP-primed and FI-RSV-boosted FcRγ −/− mice displayed less protective efficacy, as shown by higher lung viral titers upon RSV challenge, compared to RSV F-VLP-primed and FI-RSV-boosted immunized wild-type mice. RSV F-VLP and FI-RSV immunization induced lower levels of neutralizing activity and interferon-γ-producing CD8 T-cells in the bronchoalveolar lavage cells of FcRγ −/− mice than in those of wild-type mice. In addition, FcRγ −/− mice displayed a trend of enhancing lung histopathology after RSV vaccination and infection. This study suggests that the FcRγ-chain plays an important role in inducing antiviral protection and CD8 T-cell responses in RSV F-VLP prime and FI-RSV boost vaccination after RSV infections.